Press releases

2012-11-22 - Stallergenes launches Oralair in France

2012-10-10 - Quarterly information: cumulative sales growth of 4.3% to end Se...

2012-09-11 - First half-year results

2012-08-28 - Stallergenes and Aerocrine sign exclusive distribution agreement

2012-07-12 - 1st half-year 2012: sales up 6%

2012-06-13 - Patrick Langlois appointed non executive chairman of the board o...

2012-05-30 - Stallergenes makes one step forward to the launch of Oralair in ...

2012-05-21 - Stallergenes has joined G5 Health

2012-05-04 - Stallergenes announces positive clinical results for its HDM imm...

2012-04-12 - Stallergenes continues to grow: 7% increase in sales, with stron...

2012-04-02 - Stallergenes has identified two candidate biomarkers of early ef...

2012-03-21 - Registration in Canada of Oralair tablet for grass pollen

2012-03-19 - 2011 Financial Results